Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.
Immunity. 2019 May 21;50(5):1188-1201.e6. doi: 10.1016/j.immuni.2019.04.001. Epub 2019 Apr 30.
Lymph nodes (LNs) play critical roles in adaptive immunity by concentrating in one location the antigens, antigen-presenting cells, and antigen-responsive lymphocytes involved in such responses. Recent studies have revealed nonrandom localization of innate and adaptive immune cells within these organs, suggesting that microanatomical positioning optimizes responses involving sparse cooperating cells. Here, we report that the peripheral localization of LN cDC2 dendritic cells specialized for MHC-II antigen presentation is matched by a similarly biased paracortical distribution of CD4 T cells directed by the chemoattractant receptor Ebi2. In the absence of Ebi2, CD4 T cells lose their location bias and are delayed in antigen recognition, proliferative expansion, differentiation, direct effector activity, and provision of help for CD8 T cell-mediated memory responses, limiting host defense and vaccine responses. These findings demonstrate evolutionary selection for distinct niches within the LN that promote cellular responses, emphasizing the critical link between fine-grained tissue organization and host defense.
淋巴结 (LNs) 通过将参与此类反应的抗原、抗原呈递细胞和抗原反应性淋巴细胞集中在一个位置,在适应性免疫中发挥关键作用。最近的研究揭示了固有和适应性免疫细胞在这些器官内的非随机定位,表明微解剖定位优化了涉及稀疏合作细胞的反应。在这里,我们报告说,专门用于 MHC-II 抗原呈递的 LN cDC2 树突状细胞的外周定位与趋化因子受体 Ebi2 指导的 CD4 T 细胞的类似偏向性皮质旁分布相匹配。在没有 Ebi2 的情况下,CD4 T 细胞失去位置偏向性,并且在抗原识别、增殖扩展、分化、直接效应活性以及为 CD8 T 细胞介导的记忆反应提供帮助方面受到延迟,从而限制了宿主防御和疫苗反应。这些发现表明,LN 内存在促进细胞反应的独特生态位是经过进化选择的,这强调了精细组织组织与宿主防御之间的关键联系。
Interdiscip Sci. 2025-6-26
Front Immunol. 2025-2-28
Proc Natl Acad Sci U S A. 2025-2-11
Cancer Immunol Immunother. 2024-10-3